Skip to main content

Launching the Breakthrough in Lupus Diagnostics

Description du projet

A novel diagnostic test for lupus

Lupus is an autoimmune disease affecting millions of people worldwide. Diagnosis is often delayed as there is no specific diagnostic tool and most symptoms resemble those of other autoimmune diseases. To address this problem, the EU-funded ClarifyLupus project has developed a novel tool for the diagnosis of lupus. Unlike autoantibodies that are highly unspecific among diseases overlapping with lupus, ClarifyLupus employs a lupus-specific biomarker whose efficacy has been validated in blood samples. This breakthrough diagnostic tool is expected to facilitate early diagnosis, helping to avoid the irreversible damage of this devastating disease.

Champ scientifique

  • /sciences médicales et de la santé/médecine fondamentale/immunologie/maladies auto-immunes
  • /sciences médicales et de la santé/sciences de la santé/santé publique et environnementale/prévention des épidémies/immunisation
  • /sciences médicales et de la santé/médecine fondamentale/toxicologie
  • /sciences naturelles/sciences chimiques/chimie analytique/spectrométrie de masse

Appel à propositions

H2020-SMEInst-2018-2020-1
Voir d’autres projets de cet appel

Régime de financement

SME-1 - SME instrument phase 1

Coordinateur

CLARIFY ANALYTICAL LDA
Adresse
Rua De Mercadores 128A
7000-872 Evora
Portugal
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Contribution de l’UE
€ 50 000